FDC Ltd.
EARNINGS PERFORMANCE
Q4FY20
REVENUE
PREVIOUS PERIOD
CURRENT PERIOD
+21.52%
895
1088
REVENUE
REVENUE
IPCA Laboratories reported increase in consolidated total income by 21.52% to Rs. 1,087.49 Crs as compared to Rs. 894.87 Crs in the corresponding quarter previous year.
Research and development during the FY2019-20 was at around 2.50%.
GUIDANCE
Management gave a guidance of 14-17% growth in the FY 2020-21 and capex for FY 2020-21 would be around Rs. 250 Crs which would be used for initial start-up cost for Dewas facility, regular capex, automation and upgradation of various software.
Guidance
EBITDA
PREVIOUS PERIOD
CURRENT PERIOD
180
179
+0.55%
EBITDA
EBITDA
The company reported marginal increase in EBITDA at Rs. 179.86 Crs as compared to Rs. 178.87 Crs in the previous year same quarter.
The company reported deterioration in EBITDA margin which stood at 16.54%
PROFIT
PREVIOUS PERIOD
CURRENT PERIOD
-13.51%
83
96
PROFIT
PROFIT
Profit after tax for the company stood at Rs. 83.05 Crs, down by 13.51% as compared to Rs. 96.02 Crs in the corresponding quarter previous year.
The company reported deterioration in PAT margin which stood 7.64%.
SUMMARY
PREVIOUS
CURRENT
1088
895
BEATS
REVENUE
+21.52%
180
179
+0.55%
INLINE
EBITDA
83
96
MISSES
PROFIT
-13.51%